title: Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study.
abstract: BACKGROUND
  Dementia takes decades to develop, and effective prevention will likely require early intervention. Thus, it is critical to identify biomarkers of preclinical disease, allowing targeting of high-risk subjects for preventive efforts. Since telomeres shorten with age and oxidative stress, both of which are important contributors to the onset of dementia, telomere length might be a valuable biomarker.
  
  
  RESULTS
  Among 62 participants of the Nurses' Health Study, we conducted neurologic evaluations, including patient and caregiver interviews, physical exam, neurologic exam, and neuropsychologic testing. We also conducted magnetic resonance imaging (MRI) in a sample of 29 of these women. In these preliminary data, after adjustment for numerous health and lifestyle factors, we found that truncated telomeres in peripheral blood leukocytes segregate with preclinical dementia states, including mild cognitive impairment (MCI); the odds of MCI were 12-fold higher (odds ratio = 12.00, 95% confidence interval 1.24-116.5) for those with shorter telomere length compared to longer telomere length. In addition, decreasing telomere length was strongly related to decreasing hippocampal volume (p = 0.038).
  
  
  CONCLUSIONS
  These preliminary data suggest that telomere length may be a possible early marker of dementia risk, and merits further study in large, prospective investigations.
authors.affiliation: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA. fgrodstein@partners.org
authors.forename: Francine
authors.initials: F
authors.lastname: Grodstein
authors.forename: Marieke
authors.initials: M
authors.lastname: van Oijen
authors.forename: Michael C
authors.initials: MC
authors.lastname: Irizarry
authors.forename: H Diana
authors.initials: HD
authors.lastname: Rosas
authors.forename: Bradley T
authors.initials: BT
authors.lastname: Hyman
authors.forename: John H
authors.initials: JH
authors.lastname: Growdon
authors.forename: Immaculata
authors.initials: I
authors.lastname: De Vivo
mesh_terms: D000368:Aged; D003072:Cognition Disorders; D003704:Dementia / Q000175:diagnosis*; D005260:Female; D006624:Hippocampus; D006801:Humans; D007962:Leukocytes / Q000648:ultrastructure; D016015:Logistic Models; D009929:Organ Size; D010865:Pilot Projects; D011237:Predictive Value of Tests; D016615:Telomere / Q000648:ultrastructure*
references.citation: Nat Rev Drug Discov. 2004 Mar;3(3):205-14
references.pmid: 15031734
references.citation: Neurology. 2002 Sep 10;59(5):746-8
references.pmid: 12221169
references.citation: Ann Neurol. 2006 Aug;60(2):181-7
references.pmid: 16807921
references.citation: Neurology. 1984 Jul;34(7):939-44
references.pmid: 6610841
references.citation: Arch Neurol. 1994 Sep;51(9):901-6
references.pmid: 8080390
references.citation: Ann Neurol. 2006 Aug;60(2):174-80
references.pmid: 16685698
references.citation: Rejuvenation Res. 2007 Mar;10(1):61-74
references.pmid: 17378753
references.citation: Nucleic Acids Res. 2002 May 15;30(10):e47
references.pmid: 12000852
references.citation: Arch Neurol. 1999 Mar;56(3):303-8
references.pmid: 10190820
references.citation: Trends Biochem Sci. 2002 Jul;27(7):339-44
references.pmid: 12114022
references.citation: Neurobiol Aging. 2003 Jan-Feb;24(1):77-84
references.pmid: 12493553
references.citation: Science. 2003 Oct 31;302(5646):830-4
references.pmid: 14593169